These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23360785)

  • 1. MicroRNAs in malignant melanoma.
    Völler D; Ott C; Bosserhoff A
    Clin Biochem; 2013 Jul; 46(10-11):909-17. PubMed ID: 23360785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of microRNAs in melanoma.
    Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
    Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signatures of microRNAs and selected microRNA target genes in human melanoma.
    Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
    Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-221 and -222 pathway controls melanoma progression.
    Felicetti F; Errico MC; Segnalini P; Mattia G; Carè A
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1759-65. PubMed ID: 18983236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
    Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
    Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep sequencing analysis of microRNA expression in human melanocyte and melanoma cell lines.
    Ding N; Wang S; Yang Q; Li Y; Cheng H; Wang J; Wang D; Deng Y; Yang Y; Hu S; Zhao H; Fang X
    Gene; 2015 Nov; 572(1):135-145. PubMed ID: 26164755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-analytical variables in miRNA analysis.
    Becker N; Lockwood CM
    Clin Biochem; 2013 Jul; 46(10-11):861-8. PubMed ID: 23466658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.
    Boyle GM; Woods SL; Bonazzi VF; Stark MS; Hacker E; Aoude LG; Dutton-Regester K; Cook AL; Sturm RA; Hayward NK
    Pigment Cell Melanoma Res; 2011 Jun; 24(3):525-37. PubMed ID: 21435193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden.
    Schramm SJ; Li SS; Jayaswal V; Fung DC; Campain AE; Pang CN; Scolyer RA; Yang YH; Mann GJ; Wilkins MR
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):708-22. PubMed ID: 23738911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
    Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
    Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
    Leibowitz-Amit R; Sidi Y; Avni D
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA regulation of melanoma progression.
    Bonazzi VF; Stark MS; Hayward NK
    Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of melanoma-related microRNAs expression during the spontaneous regression of cutaneous melanomas in MeLiM pigs.
    Baco M; Chu CY; Bouet S; Rogel-Gaillard C; Bourneuf E; Le Provost F; Chu CY; Vincent-Naulleau S
    Pigment Cell Melanoma Res; 2014 Jul; 27(4):668-70. PubMed ID: 24661544
    [No Abstract]   [Full Text] [Related]  

  • 14. The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas.
    Bolander A; Agnarsdóttir M; Strömberg S; Ponten F; Hesselius P; Uhlen M; Bergqvist M
    Cancer Genomics Proteomics; 2008; 5(6):293-300. PubMed ID: 19287070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.
    Wang K; Zhang ZW
    Int J Clin Exp Pathol; 2015; 8(10):13249-54. PubMed ID: 26722525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [miRNAs in cancer: the case of liver tumors].
    Ladeiro Y; Zucman-Rossi J
    Med Sci (Paris); 2009 May; 25(5):467-72. PubMed ID: 19480827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of nm23-H1 in uveal melanoma.
    Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
    Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA in non-melanoma skin cancer.
    Sand M; Sand D; Altmeyer P; Bechara FG
    Cancer Biomark; 2012; 11(6):253-7. PubMed ID: 23248183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin, and procollagen-I forming specific channel structures for invasion.
    Kääriäinen E; Nummela P; Soikkeli J; Yin M; Lukk M; Jahkola T; Virolainen S; Ora A; Ukkonen E; Saksela O; Hölttä E
    J Pathol; 2006 Oct; 210(2):181-91. PubMed ID: 16924594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA miR-125b induces senescence in human melanoma cells.
    Glud M; Manfé V; Biskup E; Holst L; Dirksen AM; Hastrup N; Nielsen FC; Drzewiecki KT; Gniadecki R
    Melanoma Res; 2011 Jun; 21(3):253-6. PubMed ID: 21460750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.